FDA Coronavirus (COVID-19) Update: August 6th, 2020
August 6, 2020
Silver Spring, MD – The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
The FDA issued its first warning letter to New Life International and its second warning letter to Fishman Chemical of North Carolina, LLC, both of which distribute chloroquine phosphate products intended to treat disease in aquarium fish.
Coronavirus
FDA Coronavirus (COVID-19) Update: August 5th, 2020
August 5, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
FDA has updated its COVID-19 Drug Shortages Response webpage to provide information regarding in-use time for certain drugs during the COVID-19 Coronavirus public health emergency.
Coronavirus
FDA Coronavirus (COVID-19) Update: August 4th, 2020
August 4, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
Coronavirus
Coronavirus (COVID-19) Update: FDA Authorizes First Tests that Estimate a Patient’s Antibodies from Past SARS-CoV-2 Infection
August 3, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) authorized the first two COVID-19 Coronavirus serology tests that display an estimated quantity of antibodies present in the individual’s blood.
Coronavirus
FDA Coronavirus (COVID-19) Update: August 1st, 2020
August 1, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) today continued to take action in the ongoing response to the COVID-19 Coronavirus pandemic:
As part of the FDA’s effort to protect consumers, the agency issued a warning letter jointly with the Federal Trade Commission to one company for selling fraudulent COVID-19 Coronavirus related products.
Coronavirus
FDA Coronavirus (COVID-19) Update: July 30th, 2020
July 31, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) is continuing to take action in the ongoing response to the COVID-19 Coronavirus pandemic:
On July 29th, FDA updated its “Food Safety and the Coronavirus Disease” webpage of Questions and Answers (Q&A).
Coronavirus
FDA Warns Companies Illegally Selling Hangover Remedies
July 30, 2020
Silver Spring, MD – Today, Thursday, July 30th, 2020, the U.S. Food and Drug Administration announced it has issued warning letters to seven companies for illegally selling unapproved products labeled as dietary supplements that claim to cure, treat, mitigate or prevent hangovers, in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
FDA cracks down on Companies selling Illegal Hangover Remedies.
FDA Coronavirus (COVID-19) Update: July 29th, 2020
July 30, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has taken action in the ongoing response to the COVID-19 Coronavirus pandemic:
On July 28th, the FDA updated the Molecular Diagnostic templates.
Coronavirus
FDA Coronavirus (COVID-19) Update: July 29th, 2020
July 29, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) announces the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
Coronavirus.
FDA Coronavirus (COVID-19) Update: July 28th, 2020
July 28, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
On July 24th, the FDA reissued the LabCorp COVID-19 RT-PCR Test emergency use authorization (EUA) to include two new indications for use: testing for people who do not have COVID-19 Coronavirus symptoms or who have no reason to suspect COVID-19 Coronavirus infection, and to allow pooled sample testing.
Coronavirus
